ALLK
Price
$1.09
Change
+$0.01 (+0.93%)
Updated
Dec 18, 04:05 PM (EDT)
76 days until earnings call
IMCR
Price
$28.02
Change
-$1.38 (-4.69%)
Updated
Dec 18, 04:18 PM (EDT)
70 days until earnings call
Ad is loading...

ALLK vs IMCR

Header iconALLK vs IMCR Comparison
Open Charts ALLK vs IMCRBanner chart's image
Allakos
Price$1.09
Change+$0.01 (+0.93%)
Volume$4.46K
CapitalizationN/A
Immunocore Holdings
Price$28.02
Change-$1.38 (-4.69%)
Volume$100
CapitalizationN/A
ALLK vs IMCR Comparison Chart
Loading...
ALLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALLK vs. IMCR commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLK is a StrongBuy and IMCR is a Hold.

COMPARISON
Comparison
Dec 18, 2024
Stock price -- (ALLK: $1.08 vs. IMCR: $29.40)
Brand notoriety: ALLK and IMCR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLK: 32% vs. IMCR: 179%
Market capitalization -- ALLK: $96.04M vs. IMCR: $1.47B
ALLK [@Biotechnology] is valued at $96.04M. IMCR’s [@Biotechnology] market capitalization is $1.47B. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLK’s FA Score shows that 1 FA rating(s) are green whileIMCR’s FA Score has 0 green FA rating(s).

  • ALLK’s FA Score: 1 green, 4 red.
  • IMCR’s FA Score: 0 green, 5 red.
According to our system of comparison, ALLK is a better buy in the long-term than IMCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLK’s TA Score shows that 6 TA indicator(s) are bullish while IMCR’s TA Score has 4 bullish TA indicator(s).

  • ALLK’s TA Score: 6 bullish, 4 bearish.
  • IMCR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, ALLK is a better buy in the short-term than IMCR.

Price Growth

ALLK (@Biotechnology) experienced а -0.46% price change this week, while IMCR (@Biotechnology) price change was -7.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +1.45%, and the average quarterly price growth was +4.23%.

Reported Earning Dates

ALLK is expected to report earnings on Mar 04, 2025.

IMCR is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMCR($1.47B) has a higher market cap than ALLK($96M). IMCR YTD gains are higher at: -56.967 vs. ALLK (-60.623). IMCR has higher annual earnings (EBITDA): -37.92M vs. ALLK (-154.72M). IMCR has more cash in the bank: 901M vs. ALLK (92.7M). ALLK has less debt than IMCR: ALLK (39M) vs IMCR (481M). IMCR has higher revenues than ALLK: IMCR (296M) vs ALLK (0).
ALLKIMCRALLK / IMCR
Capitalization96M1.47B7%
EBITDA-154.72M-37.92M408%
Gain YTD-60.623-56.967106%
P/E RatioN/AN/A-
Revenue0296M-
Total Cash92.7M901M10%
Total Debt39M481M8%
FUNDAMENTALS RATINGS
ALLK: Fundamental Ratings
ALLK
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
23
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALLKIMCR
RSI
ODDS (%)
Bearish Trend 6 days ago
90%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
70%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
87%
MACD
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
76%
Declines
ODDS (%)
Bearish Trend 8 days ago
86%
Bearish Trend 6 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
82%
View a ticker or compare two or three
Ad is loading...
ALLK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IMCR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
VLSIX19.41N/A
N/A
Virtus KAR Long/Short Equity I
PAULX42.14-0.19
-0.45%
T. Rowe Price US Large-Cap Core Adv
NGUAX30.17-0.16
-0.53%
Neuberger Berman Large Cap Growth Inv
BRULX15.50-0.10
-0.64%
MFS Blended Research Value Equity R3
HBMCX27.74-0.29
-1.03%
Hartford MidCap HLS IB

ALLK and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLK has been loosely correlated with AXON. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLK jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLK
1D Price
Change %
ALLK100%
+1.42%
AXON - ALLK
38%
Loosely correlated
-2.09%
PRME - ALLK
35%
Loosely correlated
-3.00%
ENSC - ALLK
34%
Loosely correlated
-0.78%
IMCR - ALLK
33%
Loosely correlated
+0.24%
ACET - ALLK
32%
Poorly correlated
-0.75%
More

IMCR and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMCR has been loosely correlated with CRBU. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if IMCR jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMCR
1D Price
Change %
IMCR100%
+0.24%
CRBU - IMCR
36%
Loosely correlated
+1.57%
PLRX - IMCR
36%
Loosely correlated
+4.74%
GLUE - IMCR
36%
Loosely correlated
-0.13%
SWTX - IMCR
36%
Loosely correlated
-0.76%
ARVN - IMCR
36%
Loosely correlated
+0.58%
More